7Vote!
Getting Better (Free subscription) | 20 hours ago
In my efforts to have a rational discussion about the H1N1 flu shot I have been increasingly confronted with the following fear, expressed most commonly by concerned mothers and teenagers: Did you see that video on Youtube about the cheerleader who got the flu shot? Something called dystonia? She can’t walk unless she goes backwards. I don’t want to risk ending up like that. Apparently...
3Vote!
THE TENSION (Free subscription) | yesterday
N ews in Balance: WASHINGTON, Nov. 20, 2009 -- An independent study by the Institute of Medicine last month resulted in broadened health coverage by the Veterans Affairs Department for Vietnam War veterans who were exposed to Agent Orange. Research found that three illnesses – B cell leukemias, Parkinson’s disease and ischemic heart disease -- possibly are associated with Agent Orange exposure....
3Vote!
Medical News Today (Free subscription) | yesterday
Beth Israel Deaconess Medical Center (BIDMC) neurologists Alvaro Pascual-Leone, MD, PhD, and Daniel Tarsy, MD, have been awarded grants totaling more than $1.5 million from the Michael J. Fox Foundation for Parkinson's Research (MJFF) to conduct investigations aimed at improving the quality of life for patients with Parkinson's disease.
3Vote!
News Scotsman (Free subscription) | 11/20/2009
A NURSING team to deal solely with Parkinson's Disease in the Lothians should herald a new era in care for the illness.
5Vote!
Newswise (Free subscription) | 11/19/2009
1) Designing Speedier Lab Tests; 2) Reducing Neurodegeneration in Parkinson's Disease; 3) Body's Own Cholesterol Processing May Lead to Innovative Therapies; 4) Making a Better Vaccine; 5) New Way to Get a Boost in Energy Disorder.
5Vote!
PR News Wire (Free subscription) | 11/19/2009
MUNSTER, Germany, November 19 /PRNewswire/ -- MONITORING FORCE GmbH announced that they have filed on November 16th, 2009 Flibanserin in the indication treatment-relevant levodopa-induced dyskinesia in Parkinson's disease for orphan drug status designation with the European Medicines Agency (EMEA). Levodopa-induced dyskinesia is a complication of the mainstay treatment in advanced Parkinson's and a...
5Vote!
Red Orbit (Free subscription) | 11/19/2009
MUNSTER, Germany, November 19 /PRNewswire/ -- MONITORING FORCE GmbH announced that they have filed on November 16th, 2009 Flibanserin in the indication treatment-relevant levodopa-induced dyskinesia in Parkinson's disease for orphan drug status designation with the European Medicines Agency (EMEA).
3Vote!
Medical News Today (Free subscription) | 11/19/2009
Australian scientists have significantly advanced our understanding of dopamine release from nerve cells, findings that should speed the development of more effective drugs for treating Parkinson's Disease. People with Parkinson's Disease suffer from muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement.
3Vote!
Medical News Today (Free subscription) | 11/19/2009
Researchers from North Carolina State University have identified a gene that tells embryonic stem cells in the brain when to stop producing nerve cells called neurons. The research is a significant advance in understanding the development of the nervous system, which is essential to addressing conditions such as Parkinson's disease, Alzheimer's disease and other neurological disorders.
3Vote!
CloningResources.com: Cloning News, (Free subscription) | 11/19/2009
Researchers from North Carolina State University have identified a gene that tells embryonic stem cells in the brain when to stop producing nerve cells called neurons. The research is a significant advance in understanding the development of the nervous system, which is essential to addressing conditions such as Parkinson's disease, Alzheimer's disease and other neurological disorders.
4Vote!
Artdaily (Free subscription) | 11/19/2009
NEW YORK, NY (AP).- American painter Irving Kriesberg has died in New York City. He combined intense abstract colors with human and animal elements. His son, Matthias, tells The New York Times his father died Nov. 11 of complications from Parkinson's disease. He was 90. Kriesberg's works appear in major museums, including New York's Museum of Modern Art and Whitney Museum of American Art, and the...
5Vote!
Newswise (Free subscription) | 11/18/2009
Beth Israel Deaconess Medical Center (BIDMC) neurologists Alvaro Pascual-Leone, MD, PhD, and Daniel Tarsy, MD, have been awarded grants totaling more than $1.5 million from the Michael J. Fox Foundation for Parkinson's Research (MJFF) to conduct investigations aimed at improving the quality of life for patients with Parkinson's disease.
4Vote!
Business Wire (Free subscription) | 11/18/2009
CHATTANOOGA, Tenn.--(BUSINESS WIRE)--When Ruth Adams’ husband Norman* was diagnosed with Parkinson’s disease 12 years ago, Mrs. Adams decided to keep her husband at home as long as possible. “I know he would do the same for me. I have no doubts,” she said. The couple’s Unum (NYSE: UNM) long term care policy pays for a daily visit from a certified aide who helps care for...
3Vote!
Medical News Today (Free subscription) | 11/18/2009
BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company's therapeutic approach for treating neurodegenerative diseases, particularly ALS and Parkinson's disease, was found to have a positive effect in a mouse model of multiple sclerosis (MS).
5Vote!
Science Daily (Free subscription) | 11/18/2009
Scientists have significantly advanced our understanding of dopamine release from nerve cells, findings that should speed the development of more effective drugs for treating Parkinson's disease. People with Parkinson's disease suffer from muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement. These primary symptoms are caused by the loss of dopamine...
3Vote!
vivianday4 | 11/17/2009
Description: Today, we tell about Parkinson's disease, a disorder of the central nervous system. Parkinson's Disease, Central Nervous System, Victims http://www.1-language.com/eslnews/science021119.htm
3Vote!
greezzo | 11/12/2009
>> Buy requip online <<< Requip has some of the same effects that a chemical called dopamine, which occurs naturally in your body.Low levels of dopamine in the brain associated with Parkinson's disease. Requip is used to treat symptoms of Parkinson's disease, such as stiffness, tremors, muscle spasms, and poor muscle control.Requip is also used to treat restless legs syndrome (RLS). Order Requip online...
4Vote!
bharatbook | 11/06/2009
World Neurodegenerative Diseases Market 2009-2024 Our new report - World Neurodegenerative Diseases Market 2009-2024 - Rising neurodegenerative disease prevalence and expanding patent populations - where are the best opportunities and how can you unlock these? The ageing of the baby-boom generation, combined with new and emerging treatments for neurodegenerative disorders - including multiple sclerosis,